July 2025 Haleon reported the continued rollout of Voltaren 24-hour Pain Relief Patch into additional European markets, including Portugal, Austria, and the UK, while introducing new patch formats and expanding systemic Voltadexibu in Germany and Italy to strengthen its pain management portfolio.
May 2025 Haleon expanded its topical pain relief portfolio by launching Voltaren 2% in China, targeting older adults with a long-lasting anti-inflammatory formulation, supporting the company's geographic expansion strategy in the pain relief segment.
May 2025 Haleon strengthened the Voltaren brand by activating its partnership as the official licensed pain relief brand of the UEFA Champions League, increasing brand visibility through in-store promotions and experiential marketing during the tournament final in Munich.